Third, the used metabolic tumor volume analogue PSMA-TV might not prove to be the most robust PSMA-PET parameter for survival analysis in the future, as artificial intelligence–derived measures could potentially yield more applicable metrics going forward. This evidence concerns the gene FOLH1 and neoplasm.